Side Effects Block Approval of Drug Combo for Treating Obesity

GAITHERSBURG, MD. — A Food and Drug Administration advisory panel voted 10 to 6 against recommending the approval of a combination of phentermine and topiramate as a weight-loss agent because of concerns over the treatment's risk-benefit profile.